Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Reexamination Certificate
2005-03-08
2005-03-08
Leith, Patricia (Department: 1654)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Peptide containing doai
C424S115000, C424S093100, C424S093300, C424S093400, C424S093450, C424S093510, C424S780000, C435S041000, C435S042000, C435S071100, C435S071200, C435S072000, C435S073000, C435S074000
Reexamination Certificate
active
06864231
ABSTRACT:
A composition is provided that includes a biologically active compound bound by a glycoprotein matrix. A method is also provided for the manufacture of a composition of the invention. The glycoprotein matrix can be formed by permitting the growth of glycoprotein producing bacteria in the presence of the active ingredient. The composition of the invention provides a method for increasing the stability and bioactivity of the active ingredient. A method is also provided for administering an active ingredient to a host by utilizing a composition of the invention.
REFERENCES:
patent: 3196018 (1965-07-01), Galler
patent: 4654373 (1987-03-01), Bertelli
patent: 4797289 (1989-01-01), Reddy
patent: 5008118 (1991-04-01), Iwanami et al.
patent: 5441737 (1995-08-01), Nitsche
patent: 5639787 (1997-06-01), Riordan et al.
patent: 5747071 (1998-05-01), Segall et al.
patent: 5773011 (1998-06-01), Grubhofer
patent: 5827886 (1998-10-01), Hersh
patent: 5891469 (1999-04-01), Amselem
patent: 5912272 (1999-06-01), Hoppe et al.
patent: 5950634 (1999-09-01), Ochi et al.
patent: 5989583 (1999-11-01), Amselem
patent: 6045826 (2000-04-01), Borowy-Borowski et al.
patent: 6054261 (2000-04-01), Masterson
patent: 6221357 (2001-04-01), Bok et al.
patent: 0409252 (1991-01-01), None
patent: 0725077 (1996-08-01), None
patent: 1064946 (2001-01-01), None
patent: WO 9617626 (1996-06-01), None
patent: WO 9830583 (1998-07-01), None
patent: WO 0043490 (2000-07-01), None
Dosti, R.; Jolly Roger's Orange Bread Melts in Mouth: [Home Edition] The Los Angeles Times (Pre-1997 Fulltext), Feb. 1989 p. 34 (pp. 1-3 on ProQuest direct web site).*
Yahoo Slow Cooker Mail List; Cherry Yogurt Bread; newsgroup string published Jan. 8, 1999, www.groups.yahoo.com/group/slowcooker/message/2396?source=1, pp. 1-3.*
Wikipedia Encyclopedia Online; Nutritional Information About the Apple; accessed on Oct. 20, 2003 from www.en.wikipedia.org/wiki/Apple/Nutritional information pp. 1-4.*
Faust, P. ;Hormones in the Gut- The Effect of Human Intestinal Bacteria on the Metabolism of Estrogen Hormones; accessed Oct. 20, 2003, copyrighted 2001, Paul Faust, N.D. Chesapeake Natural Health Center pp. 1-4.*
McGovern, S. Stonyfield Farm Yogurt Launches 'Big Gurt'; PR Newswire, New York, May 8, 1995 (pp. 1-2).*
Navarro, et al., “Protective Role in Ubiquinone in Vitamin E and Selenium-Deficient Plasma Membranes”,BioFactors 9, pp. 163-170 (1999).
Hoppe, et al., “Coenzyme Q10, a Cutaneous Antioxidant and Energizer”,BioFactors 9, pp. 371-378 (1999).
Hodges, et al., “CoQ10: Could It Have a Role in Cancer Management?”,BioFactors 9, pp. 365-370 (1999).
Langsjoen, et al., “Overview of the Use of CoQ10in Cardiovascular Disease”,BioFactors 9, pp. 273-284 (1999).
Baroni, et al., “Monounsaturated Diet Lowers LDL Oxidisability in Type Iib and Type IV Dyslipidemia Without Affecting Coenzymes Q10and Vitamin E Contents”,BioFactors 9, pp. 325-330 (1999).
Pedersen, et al., “High Serum Coenzyme Q10, Positively Correlated with Age, Selenium and Cholesterol, in Inuit of Greenland. A Pilot Study.”,BioFactors 9, pp. 319-323 (1999).
Niibori, et al., “Bioenergetic Effect of Liposomal Coenzyme Q10on Myocardial Ischemia Reperfusion Injury”,BioFactors 9, pp. 307-313 (1999).
Tomasetti, et al., “Distribution of Antioxidants Among Blood Components and Lipoproteins: Significance of Lipids/CoQ10Ratio as a Possible Marker of Increased Risk for Atherosclerosis”,BioFactors 9, pp. 231-240 (1999).
Chida, et al., “In vitro Testing of Antioxidants and Biochemical End-Points in Bovine Retinal Tissue”,Ophthalmic Research, 31: 407-415 (1999).
Bianchi, et al., “Oxidative Stress and Anti-Oxidant Metabolites in Patients with Hyperthyroidism: Effect of Treatment”,Horm. Metab. Res., 31: 620-624 (1999).
Al-Bekairi, et al., “Coenzyme Q10Ameliorates the Hepatic Toxicity Induced by Carbon Tetrachloride in Mice”,Research Communications in Pharmacology and Toxicology, vol. 4, Nos. 3 & 4, pp. 163-171 (1999).
Yokoyama, et al., “Coenzyme Q10Protects Coronary Endothelial Function from Ischemia Reperfusion Injury Via an Antioxidant Effect”,Surgery, vol. 120, No. 2, pp. 189-196 (1996).
Morita, et al., “Studies of Hypoxemic/Reoxygenation Injury: Without Aortic Clamping VII. Counteraction of Oxidant Damage by Exogenous Antioxidants: Coenzyme Q10”,The Journal of Thoracic and Cardiovascular Surgery, vol. 110, No. 4, Part 2, pp. 1221-1227 (1995).
Lass, et al., “Effects of Coenzyme Q10and α-Tocopherol Administration on Thier Tissue Levels in the Mouse: Elevation of Mitochondrial α-Tocopherol by Coenzyme Q10”,Free Radical Biology&Medicine, vol. 26, Nos. 11/12, pp. 1375-1382 (1999).
Nielsen, et al., “No Effect of Antioxidant Supplementation in Triathletes on Maximal Oxygen Uptake,31P-NMRS Detected Muscle Energy Metabolism and Muscle Fatigue”,Int. J. Sports Med., 20: 154-158 (1999).
Alleva, et al., “Oxidation of LDL and Their Subfractions: Kinetic Aspects and CoQ10Content”,Molec. Aspects Med., vol. 18 (Supplement), pp. S105-s112 (1997).
Tomasetti, et al., “Coenzyme Q10Enrichment Decreases Oxidative DNA Damage in Human Lymphocytes”,Free Radical Biology&Medicine, vol. 27, Nos. 9/10, pp. 1027-1032 (1999).
Aejmelaeus, et al., “Ubiquinol-10 and Total Peroxyl Radical Trapping Capacity of LDL Lipoproteins During Aging: the Effects of Q-10 Supplementation”,Molec. Aspects Med., vol. 18 (Supplement), pp. s113-s120 (1997).
Hoffmann & Baron , LLP
Leith Patricia
Pharmachem Laboratories, Inc.
LandOfFree
Glycoprotein matrix compositions and methods related thereto does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Glycoprotein matrix compositions and methods related thereto, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Glycoprotein matrix compositions and methods related thereto will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3440838